The Impact of eClinical Technologies on Clinical Trials
The word “transformational” is frequently used by eClinical solution vendors and clinical trials professionals to describe platforms, solutions and applications of technology. Sometimes that transformation is significant and fast moving, centered on one part of the clinical trial ecosystem such as the advances in remote data capture that gave us today’s “new normal” of EDC. Sometimes the transformation happens over decades, for example the use of interactive response technology has been a key facilitator of increasingly complex packaging strategies, visit and dosing schedules. More recently, electronic trial master files have begun to automate the study filing process; a substantial change to the way we maintain inspection readiness. Yet in most cases the eClinical solution primarily automates an existing business process; as ATMs automated the work of bank tellers, EDC automated the job of getting data from site to statistician.
Disruption over Transformation
So whilst eClinical technologies have undoubtedly transformed many aspects of clinical trial planning and execution, have they truly disrupted it? Take Uber in comparison.